Back to REGN Stock Lookup
Pages: 1 2 3 »» Last Page

REGN Related Analyst Ratings

Jun 18, 2013 07:11 AM Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
May 17, 2013 06:46 AM UBS Starts Regeneron Pharma (REGN) at Neutral
May 3, 2013 02:41 PM Brean Capital Upgrades Regeneron Pharma (REGN) to Buy, PT $315
May 2, 2013 07:23 AM JMP Securities Upgrades Regeneron Pharma (REGN) to Market Outperform
May 1, 2013 12:55 PM Reduced Competition Adds $35 to Regeneron (REGN) DCF, Deutsche Bank Raises PT to $310
Apr 9, 2013 08:58 AM Goldman Sachs Raises Price Target on Regeneron (REGN) to $215
Apr 3, 2013 09:59 AM Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)
Mar 28, 2013 06:52 AM JMP Securities Starts Regeneron Pharma (REGN) at Market Perform
Feb 28, 2013 06:53 AM Barclays Starts Regeneron Pharma (REGN) at Overweight
Jan 17, 2013 08:23 AM Brean Capital Downgrades Regeneron Pharma (REGN) to Hold
Jan 15, 2013 02:23 PM Baird Releases Bullish Note on Regeneron (REGN), Eylea Taking Share
Jan 15, 2013 07:12 AM Jefferies Downgrades Regeneron Pharma (REGN) to Hold, Sees Limited Eylea Upside
Nov 20, 2012 10:07 AM Regeneron (REGN) Pops Higher; Deutsche Sees AAO/ASRS as Positive for Branded Drugs
Nov 13, 2012 06:54 AM Credit Suisse Starts Regeneron Pharma (REGN) at Outperform
Nov 7, 2012 10:09 AM RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity
Oct 22, 2012 02:26 PM Leerink Swann Raises Price Target on Regeneron (REGN) to $182
Oct 18, 2012 10:51 AM Regeneron (REGN) May See Pressure in U.S. Over Zaltrap Pricing (SNY)
Oct 16, 2012 03:38 PM Regeneron (REGN) Could Benefit as Avastin Suffers as Result of Meningitis Outbreak
Oct 4, 2012 12:54 PM Baird Boosts Price Target on Regeneron (REGN) as Survey Indicates Positive Eylea Momentum
Aug 7, 2012 07:50 AM Lazard Capital Starts Regeneron Pharma (REGN) at Neutral
Jul 25, 2012 12:27 PM BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform
Jul 25, 2012 11:09 AM Deutsche Bank Reiterates Bullish Stance on Regeneron (REGN)
Jun 13, 2012 11:35 AM Deutsche Bank Says Fovista Will Be Complement to Regeneron's (REGN) Eylea, Not Competitor
Jun 1, 2012 12:04 PM Regeneron (REGN) Shares Punished as Analyst Warns on Eylea Growth
May 9, 2012 11:59 AM Jefferies Trims Target on Regeneron Pharma (REGN) After Arcalyst News, Keeps Buy Rating
Apr 27, 2012 08:42 AM Jefferies Lifts Numbers on Regeneron Pharma (REGN)
Apr 27, 2012 07:55 AM BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform
Apr 25, 2012 11:05 AM Baird Maintains an 'Outperform' on Regeneron Pharma (REGN); Still Taking Share AND Growing the Branded Market
Apr 12, 2012 10:14 AM Declining Lucentis Market Share Bodes Well for Regeneron's (REGN) Eylea -BMO
Apr 2, 2012 06:45 AM Goldman Sachs Starts Regeneron Pharma (REGN) at Buy, Sees 23% Upside
Mar 29, 2012 03:24 PM Baird Reiterates a 'Outperform' on Regeneron Pharma (REGN); Bullish Thesis Intact
Mar 27, 2012 08:26 AM Baird Sees More Upside on Regeneron Pharma (REGN), Lifts Price Target
Mar 21, 2012 10:49 AM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); View ACC As Coming Out Party
Mar 12, 2012 08:24 AM BofA/Merrill Lynch added Regeneron Pharmaceuticals (REGN) to its U.S. 1 List
Mar 9, 2012 08:13 AM Jefferies Sees More Upside for Regeneron Pharma (REGN)
Mar 5, 2012 08:05 AM Leerink Swann Reiterates an 'Outperform' on Regeneron Pharma (REGN); Survey Says: Solid Eylea Outlook in U.S.
Feb 15, 2012 10:44 AM Deutsche Bank Reiterates a 'Buy' on Regeneron Pharma (REGN); Fake Avastin - Our Take on Read Across to REGN's Eylea
Feb 14, 2012 08:13 AM Jefferies Boosts Numbers On Regeneron (REGN) After Strong Q4, Outlook
Feb 13, 2012 04:12 PM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); EYLEA Train Keeps On Rollin'....Raising Numbers Again
Feb 7, 2012 07:32 AM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); Think This Stock Still Has Legs
Feb 6, 2012 03:27 PM Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Feb 6, 2012 08:35 AM Piper Jaffray Downgrades Regeneron (REGN) to Neutral
Feb 6, 2012 07:36 AM Jefferies Raises Price Target On Regeneron Pharma (REGN) to $111
Feb 3, 2012 07:51 AM ThinkEquity Starts Regeneron Pharma (REGN) at Buy, Sets $120 Price Target
Jan 30, 2012 08:09 AM BofA/Merrill Lynch Upgrades Regeneron Pharma (REGN) to Buy
Jan 17, 2012 07:57 AM Roth Capital Downgrades Regeneron Pharma (REGN) to Neutral
Jan 10, 2012 12:08 PM Leerink Swann reiterates an 'Outperform' on Regeneron Pharma (REGN); Eylea Posts an Eye-Popping 1st Quarter of Launch
Jan 10, 2012 12:03 PM Brean Murray Carret & Co. maintains a 'Buy' on Regeneron Pharma (REGN); Adjusting Eylea Sales Upward
Jan 10, 2012 11:57 AM Deutsche Bank Raises Price Target on Regeneron Pharma (REGN); First Glimpse at Execution Ability
Jan 10, 2012 07:16 AM Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake
Pages: 1 2 3 »» Last Page

Back to REGN Stock Lookup